Medtronic PLC to Issue Quarterly Dividend of $0.71 (NYSE:MDT)

Medtronic PLC (NYSE:MDT) announced a quarterly dividend on Thursday, March 5th. Stockholders of record on Friday, March 27th will be paid a dividend of 0.71 per share by the medical technology company on Friday, April 17th. This represents a c) dividend on an annualized basis and a dividend yield of 3.1%. The ex-dividend date is Friday, March 27th.

Medtronic has raised its dividend payment by an average of 0.1%per year over the last three years and has increased its dividend annually for the last 49 consecutive years. Medtronic has a payout ratio of 47.2% indicating that its dividend is sufficiently covered by earnings. Equities research analysts expect Medtronic to earn $5.83 per share next year, which means the company should continue to be able to cover its $2.84 annual dividend with an expected future payout ratio of 48.7%.

Medtronic Stock Performance

MDT opened at $92.96 on Friday. Medtronic has a 12-month low of $79.55 and a 12-month high of $106.33. The firm has a market capitalization of $119.35 billion, a P/E ratio of 25.89, a price-to-earnings-growth ratio of 2.40 and a beta of 0.71. The stock’s 50 day moving average price is $98.80 and its two-hundred day moving average price is $96.95. The company has a quick ratio of 1.87, a current ratio of 2.54 and a debt-to-equity ratio of 0.57.

Medtronic (NYSE:MDT) last announced its earnings results on Tuesday, February 17th. The medical technology company reported $1.36 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.34 by $0.02. The business had revenue of $9.02 billion for the quarter, compared to analyst estimates of $8.89 billion. Medtronic had a net margin of 13.00% and a return on equity of 14.82%. Medtronic’s revenue was up 5.8% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.38 earnings per share. Medtronic has set its FY 2026 guidance at 5.620-5.660 EPS. On average, equities analysts forecast that Medtronic will post 5.46 earnings per share for the current year.

About Medtronic

Medtronic plc is a global medical technology company that develops and manufactures a broad range of therapeutic devices and health care solutions. Headquartered legally in Ireland with principal operational offices in the United States, the company markets products to hospitals, physicians and health systems worldwide and has grown from its founding in 1949 into one of the largest medical-device manufacturers serving global health-care markets.

Medtronic’s offerings span several clinical areas, including cardiac rhythm and heart failure (pacemakers, implantable cardioverter‑defibrillators and related cardiac therapies), minimally invasive and surgical technologies (laparoscopic and advanced energy devices, visualization systems and surgical innovations), restorative therapies (spine and orthopedics, neuromodulation and neurovascular treatments) and diabetes management (insulin-delivery systems and glucose monitoring solutions).